MedPath

AVOTRES INC

AVOTRES INC logo
🇺🇸United States
Ownership
Holding
Established
2016-01-01
Employees
1
Market Cap
-
Website
http://www.avotres.com

Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes

Phase 1
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Other: Placebo
First Posted Date
2019-03-29
Last Posted Date
2025-03-05
Lead Sponsor
Avotres Inc.
Target Recruit Count
25
Registration Number
NCT03895996
Locations
🇺🇸

Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath